Share this article
Share this article
ResearchAndMarkets.com s offering.
The Global Clinical Trials Market was valued at USD51.25 billion in 2020 and is anticipated to reach USD77.20 billion by 2026, registering a CAGR of 7.10% in the next five years.
The market is driven by the outbreak of tropical and infectious diseases such as COVID-19, which has led to extensive clinical trials around the world in order to find the suitable treatment and vaccine.
Also, the digitization of clinical trials is anticipated to propel the growth of this market in the coming years.
Additionally, the increasing prevalence of chronic diseases and growing need for personalized drugs are some other key factors propelling the growth of the Global Clinical Trials Market. Governments in various economies are also providing favorable support for clinical trials in order to find the cure for deadly diseases like coronavirus. The increasing expenditure on R&D activities and rise in biotechnology firms i
Global Clinical Trials Market 2021 to 2026 Analysis by Top Key players like Quintiles IMS, PRA Health Sciences, ICON plc, Paraxel International Corporation, Wuxi AppTec Inc , etc – KSU
ksusentinel.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ksusentinel.com Daily Mail and Mail on Sunday newspapers.
Clinical Trials Market Research Methods that Will Give You Proven Results | Forecast 2021-2027 | company1,company2,company5 – KSU
ksusentinel.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ksusentinel.com Daily Mail and Mail on Sunday newspapers.
ECOA, eSource & Clinical Trials Market 2021: Global Industry Analysis Report to 2029
briefingwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from briefingwire.com Daily Mail and Mail on Sunday newspapers.
Share this article
SAN FRANCISCO, April 13, 2021 /PRNewswire/ The global virtual clinical trials market size is expected
to reach USD 11.5 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected
to expand at a CAGR of 5.7% from 2021 to 2028. The need for patient diversity clubbed with enhanced data collection in clinical trials is boosting virtual/decentralized clinical trials (DCTs) market growth.
Key suggestions from the report:
The oncology segment held 25.0% of the market share in 2020. The increasing adoption of virtual trials especially in oncology research for the diverse population is responsible for the growth of the segment